PLI schemes boost India’s pharma, medtech manufacturing: Report

India’s Production Linked Incentive (PLI) schemes have reportedly boosted domestic production of bulk drugs, pharmaceuticals & medical devices, reducing import dependence and attracting investment. By June 2026, pharma PLI investments had reached ₹46,744 crore. Domestic production has expanded across APIs, complex medicines & high-end devices, including MRI machines, CT scanners and heart valves.